23 Matching Annotations
  1. Last 7 days
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12703355/
  3. Aug 2025
  4. www.sciencedirect.com www.sciencedirect.com
    Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLC
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004225014725
  5. Jul 2025
  6. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    68Ga-NK224 PET/CT for Noninvasive Evaluation of PD-L1 Expression and Intertumor Heterogeneity: A Translational Exploratory Study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12260512/
  7. May 2025
  8. www.sciencedirect.com www.sciencedirect.com
    Benmelstobart plus anlotinib and chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: A phase 2 study
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379125002186
  9. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Tumor diagnosis recharacterization enabled by comprehensive genomic profiling to guide precision medicine strategy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12095656/
  10. 52.53.155.43 52.53.155.43
    PDF-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/1f223659e065ae2334abaabf911eb2b757fce79a/PDF-html.html
  11. Apr 2025
  12. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11995005/
  13. aacrjournals.org aacrjournals.org
    The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Phase 1b/2a Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/31/4/649/751732/The-Prostaglandin-EP4-Antagonist-Vorbipiprant
  14. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic Targets
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11949235/
  15. Mar 2025
  16. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Multimodal deep learning for predicting PD-L1 biomarker and clinical immunotherapy outcomes of esophageal cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11933072/
  17. Feb 2025
  18. 52.53.155.43 52.53.155.43
    ccr-24-2611-html.html
    3
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/10176dad0a87cf11fc538ab55acf72e3023d9cdd/ccr-24-2611-html.html
  19. aacrjournals.org aacrjournals.org
    Eftilagimod alpha (soluble LAG-3 protein) combined with pembrolizumab as second-line therapy for patients with metastatic head and neck squamous cell carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/30/17/3726/747260/Eftilagimod-Alpha-Soluble-LAG3-Protein-Combined
  20. Dec 2024
  21. www.cell.com www.cell.com
    Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell-reports-medicine/abstract/S2666-3791(24)00650-5
  22. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11609623/
  23. Aug 2024
  24. www.sciencedirect.com www.sciencedirect.com
    Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610824002691
  25. Jun 2024
  26. www.sciencedirect.com www.sciencedirect.com
    First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666634024002137
  27. Oct 2023
  28. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10588513/
  29. Aug 2023
  30. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10425723/
  31. Jun 2023
  32. www.sciencedirect.com www.sciencedirect.com
    Machine learning-based risk model incorporating tumor immune and stromal contexture predicts cancer prognosis and immunotherapy efficacy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004223011355
  33. Apr 2023
  34. acsjournals.onlinelibrary.wiley.com acsjournals.onlinelibrary.wiley.com
    Vimentin expression correlates with immune-checkpoint inhibitor efficacy in non–small cell lung cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34782
  35. Sep 2022
  36. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9459341/